Hans Hull insider trades

Open-market stock purchases and sales by Hans Hull, Chief Business Officer at Pliant Therapeutics, Inc, from SEC Form 4 filings since Jul 30, 2014.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • PLRX Pliant Therapeutics, Inc: 9 sales, last Jan 23, 2025
  • AAVL Avalanche Biotechnologies, Inc: 3 sales, last Aug 21, 2015
  • [AAVL] Avalanche Biotechnologies, Inc: 1 sale, last Jun 4, 2015

Get free alerts when Hans Hull files a new trade →